Aspinwall and Company Limited Overview
Aspinwall and Company is one of the oldest surviving commercial houses on India's Malabar Coast. It is a 159-year-old, family-controlled, diversified micro-cap run by members of the erstwhile Royal Family of Travancore, who have held control since the early 1970s. The company operates four modest but distinct businesses. The first is port-centric logistics and customs brokerage across southern and western India. The second is the procurement, curing and export of specialty Indian coffees, notably Monsooned Malabar, mainly to European roasters. The third is a natural-rubber estate of roughly 2,200 acres in Malappuram, Kerala. The fourth is a small coir and natural-fibre manufacturing operation. Revenue reached INR 417 crore in FY2026, up 24% year on year. Margins, however, are thin and volatile: operating margin has stayed in a 3–8% band for five years, and net margin was about 3%. The investment case therefore rests less on growth than on three things: a conservative balance sheet, an unbroken dividend record, and a share price below book value.
The company's own description
The FY2025-26 Directors' Report describes Aspinwall as a diversified business entity. It names five activities: logistics services, coffee processing and trading, rubber plantations, and the manufacture and trading of natural fibre products and mattresses. Screener's summary of the FY2026 Annual Report adds commercial real-estate leasing of the company's "Aspinwall House" premises as a further activity. The Directors' Report says the company is working to use its facilities more fully to raise revenue from them. Morningstar's profile, drawn from filings, states that the reportable segments are Logistics, Coffee, Plantation and Others.
Independent characterization
Aspinwall is best understood as a working-capital-intensive agri-commodity exporter combined with an asset-light trade-services business, held together by a family holding structure. It is not a single integrated value chain. The two main businesses, Coffee and Logistics, produced about 81% of FY2026 revenue (CRISIL describes the pair as "nearly 80%"). They have different economics:
Coffee: is a merchant-processor model. Aspinwall buys green coffee, mainly from Karnataka and Kerala growers and traders. It then cures, grades, "monsoons" and exports it. Profit is a processing-and-trading spread, and it is exposed to two things: ICE coffee futures and domestic procurement prices. Profitability also depends heavily on inventory, because CRISIL notes a processing and sales cycle of 6–9 months.
Logistics: is a fee-based service model. The company acts as customs house agent, liner and ship agent, handles bulk cargo, provides stevedoring, freight forwarding, air cargo (IATA-accredited), warehousing, and project or over-dimensional cargo handling. Margins are steady at about 8–10% of segment revenue. Volumes follow India's EXIM trade cycle and port-specific bulk flows, particularly at Mangaluru.
Plantation: is a natural-rubber estate. It produces centrifuged latex and technically specified natural rubber, and also makes Esophageal Varices Ligation (EVL) bands, a medical consumable. Earnings follow rubber prices and the age profile of the trees.
Others: consists mainly of natural fibre (coir mats, mattings, rugs, runners, mattresses and coir geotextiles through a subsidiary), healthcare products and minor trading. This segment has been at or below breakeven for most of the last five years.
Revenue model mix
| Revenue type | Businesses | Approximate share of FY2026 revenue | Basis |
|---|---|---|---|
| Product sales (commodity and manufactured goods) | Coffee, Plantation (rubber, latex, EVL bands), Natural fibre, Healthcare | About 62% | Zonebourse segment data: Coffee + Plantation + Others = INR 256.7 crore out of 416.7 crore |
| Service fees | Logistics (CHA, freight forwarding, ship agency, stevedoring, warehousing), pharma logistics (SFS) | About 38% | Logistics segment INR 160 crore |
| Rental/leasing | Aspinwall House premises | Not separately disclosed (immaterial; included in other income or Others) | Directors' Report FY2026 mentions leasing optimisation |
| Subscription/licensing | — | 0% | — |
Value-chain position, customers and end-markets
| Business | Value-chain position | Customer types | End-markets |
|---|---|---|---|
| Coffee | Mid-stream: procurement, curing, monsooning, grading, export | Specialty and commercial roasters, green-coffee importers | Exports, about 85% to Switzerland, Germany, Italy, the UK and Scandinavia; the balance to Australia, the USA, Japan and Russia (company disclosure cited by TradingView research); plus domestic sales |
| Logistics | Intermediary service provider at ports, ICDs and airports | Exporters, importers, shipping lines, project cargo owners, pharma and clinical-trial sponsors (via SFS Pharma Logistics) | Indian EXIM trade, bulk commodities, project cargo |
| Plantation | Upstream grower and primary processor | Tyre and rubber-goods manufacturers, latex users, hospitals and distributors (EVL bands) | Domestic natural-rubber market; medical devices |
| Natural fibre | Manufacturer and exporter | Retailers and importers of floor coverings; domestic mattress buyers; infrastructure and erosion-control buyers (geotextiles) | The USA, Europe and India |
Strategy
Stated strategic themes (FY2025-26 Annual Report, paraphrased)
Aspinwall publishes no investor-day material or formal medium-term strategy. The strategic signals in the FY2026 Directors' Report and Management Discussion & Analysis are:
-
Plantation productivity: a long-term programme to extend the economic life of rubber trees from 25 to 32 years, which the company says is showing positive early results.
-
Asset monetisation: using the Aspinwall House facilities more fully to raise leasing revenue.
-
Logistics branch performance: improvement at individual branches, with Chennai cited.
-
Natural Fibre defence: coping with weaker domestic mattress demand and US tariff-driven price cuts. No restructuring has been announced.
-
Cost vigilance: the company flags risk from Middle East conflict inflating raw-material, packaging and logistics costs.
-
Subsidiary momentum: the SFS Pharma Logistics discussion in the Directors' Report states confidence that positive business momentum will continue into FY2026-27.
Initiative register (last 24 months)
| Initiative | Date / status | Type | Target or metric disclosed | Source |
|---|---|---|---|---|
| Rubber tree life extension (25 to 32 years) | Ongoing; early results positive (FY2026 AR) | Productivity | None quantified | Directors' Report FY2026 |
| Aspinwall House leasing optimisation | Ongoing | Asset monetisation | None quantified | Directors' Report FY2026 |
| Enhancement of bank working-capital lines (INR 126.5 crore to INR 153.5 crore) | September 2026 | Financing | Supports inventory-heavy coffee growth | CRISIL 28-Sep-2026 |
| Healthcare products (Aspinwall Healthcare) | Since 2020; ongoing | New business | None disclosed | CRISIL |
| EVL band manufacturing | Ongoing | Product diversification | None disclosed | IIFL |
| Transformation programmes, cost programmes with targets | None announced | — | — | — |
| ESG or sustainability commitments | None publicly announced | — | — | — |
Medium-term guidance
Not publicly disclosed. Management does not issue financial guidance. CRISIL's forward view, which is not company guidance, expects annual net cash accrual of INR 9–11 crore and no significant debt-funded capex.
Products & Services
Pricing models are not publicly disclosed for any product. The company publishes no product-level revenue. Launch years are given only where disclosed.
Logistics segment
| Offering | Description and capabilities | Target customer | Launch/notes | Source |
|---|---|---|---|---|
| Customs House Agency (CHA) | Customs clearance and documentation at major ports, ICDs and airports | Exporters and importers | Long-standing; network of about 9–11 branches | Wright Research; IIFL |
| Liner services and ship agency | Agency for shipping lines and vessel calls; port agency, spare-parts handling, bunker and fuel supply coordination | Shipping lines and ship owners | Shipping heritage since 1867 | Wright Research; MagicPort |
| Bulk cargo handling and stevedoring | Loading and unloading of bulk commodities, notably at Mangaluru port | Bulk commodity shippers | Mangaluru bulk cargo volume is tracked as a KPI (figure not public) | Screener insights |
| Air cargo | IATA-accredited cargo agency | Time-sensitive exporters | — | Tradomate summary |
| Freight forwarding | International sea and air freight forwarding | Shippers | — | Wright Research |
| Project and over-dimensional cargo (ODC) | Customs clearance, handling and transport of heavy-lift and ODC consignments | EPC contractors and project owners | Handled "major projects" (no list disclosed) | IIFL summary |
| Warehousing | Storage and handling | Shippers and traders | — | Wright Research |
| Pharma and clinical-trial logistics (SFS Pharma Logistics) | Specialised logistics for clinical-trial shipments and pharmaceutical products | Pharma companies and CROs | Entity incorporated 2011 | CRISIL |
| Marine services (Malabar Coast Marine Services) | Logistics and marine-related services | Shipping and port users | Entity incorporated 1990 | CRISIL |
Coffee segment
| Offering | Description | Target customer | Notes | Source |
|---|---|---|---|---|
| Monsooned Malabar AA | Arabica beans exposed to monsoon winds on the Malabar coast, which gives low acidity and a heavy body; a geographical-indication coffee of India | Specialty roasters (Europe) | Flagship specialty grade | Wright Research |
| Monsooned Robusta AA | Robusta beans processed by monsooning | Espresso blenders and roasters | Flagship specialty grade | Wright Research |
| Other green coffee grades (arabica and robusta) | Purchasing, curing, grading and export of commercial and specialty green coffee | Importers and roasters | Grade list not disclosed | Morningstar |
| Coffee curing and processing works | Mangaluru (Kulshekar) curing and processing facility | Captive | Processing and sales cycle of 6–9 months per CRISIL | CRISIL |
| Export sales office | 's-Hertogenbosch, Netherlands | European buyers | — | Morningstar; IIFL |
Plantation segment
| Offering | Description | Target customer | Notes | Source |
|---|---|---|---|---|
| Natural rubber estate | About 2,200 acres of rubber plantations in Malappuram district, Kerala | — | Strategy to extend economic tree life from 25 to 32 years is showing early positive results (FY2026 Directors' Report) | Simply Wall St; Directors' Report |
| Centrifuged latex | Concentrated latex for dipped goods | Latex-goods makers | — | IIFL; Simply Wall St |
| Technically specified natural rubber (ISNR/TSR) | Graded block rubber | Tyre and rubber-goods makers | — | IIFL |
| EVL bands / multi-band ligator | Medical consumable for endoscopic ligation of esophageal varices, made at the plantation division | Hospitals and medical distributors | Diversification "of late"; launch year not disclosed | IIFL; PL India |
Others segment (Natural Fibre, Healthcare, miscellaneous)
| Offering | Description | Target customer | Notes | Source |
|---|---|---|---|---|
| Coir entrance and corridor mats | Handloom and power-loom coir mats | Retailers and importers (USA, Europe) | Pollachi (and historically Alleppey) | Wright Research |
| Mattings, carpets, rugs, runners | Natural-fibre floor coverings; in-house design centre and custom designs to buyer specifications | Importers and retail chains | — | IIFL |
| Mesh mattings | Coir mesh products | Commercial buyers | — | Wright Research |
| Coir mattresses | Natural-fibre mattresses | Indian consumers | Sharp fall in domestic sales in FY2026 | FY2026 Directors' Report |
| Coir geotextiles (Aspinwall Geotech) | Erosion control and soil conservation products | Infrastructure contractors and government agencies | — | CRISIL |
| Medical products (Aspinwall Healthcare) | Manufacturing and trading of medical products, accessories and equipment | Healthcare buyers | Since 2020 | CRISIL |
| Virgin coconut oil | Premium virgin coconut oil trading | Consumers and retailers | Launched 2020 | Pocketful; Tradomate |
| Premises leasing (Aspinwall House) | Commercial leasing of company premises | Corporate tenants | Revenue not separately disclosed | Screener key points; Directors' Report |
Financial Narrative
Basis. Consolidated figures. Source: Screener.in, compiled from company filings and accessed October 2026. FY2025 and FY2026 revenue and PAT were cross-checked with CRISIL and ScanX (company filing summaries). Screener rounds to whole crore, so ratios computed from it carry rounding error of about ±1 crore. Precise FY2025 and FY2026 figures are used where available.
Income statement
Notes. EPS is the same on a basic and diluted basis because there are no dilutive instruments. FY2024 and FY2026 DPS are confirmed from NSE filings (60% of INR 10 face value in FY2024, INR 6.50 in FY2026). FY2025 DPS of INR 6.50 is confirmed by TipRanks/TradingView as the last paid dividend. FY2022 and FY2023 DPS are derived from Screener's payout ratios (31% and 16%) and are consistent with INR 6. Gross profit is not reported in a consistent multi-year form. Simply Wall St shows a trailing gross profit of INR 150 crore on revenue of INR 380 crore (TTM to December 2025), which implies a gross margin of about 39%. Gross margin is therefore excluded from the chartable tables.
Margins and growth (analyst-computed)
Revenue CAGR. The four-year CAGR from FY2022 to FY2026 is about 12.5% (INR 260 crore to INR 417 crore). The five-year CAGR from FY2021 (INR 253 crore) to FY2026 is about 10.5%, matching Screener's reported 5-year sales growth of 10.5%. Profit CAGR is much weaker. Screener reports compounded profit growth of 4% over five years and minus 21% over three years, because FY2023 profit was inflated by INR 21 crore of other income.
Quarterly trajectory (consolidated)
Source: Screener.in quarterly consolidated data. Q1 FY2027 cross-checked with Business Standard/Capital Market (6 August 2026) and the NSE board outcome of 5 August 2026, which reported a consolidated loss of INR 70 lakh and a standalone loss of INR 134 lakh.
Seasonality. The first quarter (April–June) has been weak in each of the last three years: Q1 FY2024 OPM was 1.0%, Q1 FY2026 was minus 2.0%, and Q1 FY2027 was 1.0%. The second half (October–March) is consistently the strongest. The coffee export calendar and rubber tapping seasonality are the likely drivers. Investors should not annualize first-quarter results.
Balance sheet
Notes and items not disclosed in the data accessed:
Cash and equivalents: Year-end balances were not available in the aggregator data used. CRISIL states that average cash and bank balances were about INR 11 crore over the 12 months to August 2026. Craft.co reports cash of INR 16.7 crore at Q2 FY2026. Net debt is therefore estimated, not reported: about INR 65–70 crore at 31 March 2026 (borrowings of INR 79 crore less roughly INR 10–15 crore of cash).
Short-term versus long-term debt: CRISIL's facility annexure shows the rated borrowings are working-capital lines: export packing credit, cash credit and working capital demand loans. CRISIL also states nil term-debt obligations over the medium term. Debt is therefore essentially all short-term working-capital finance.
Goodwill and intangibles: Not separately disclosed; believed immaterial given that the subsidiaries were formed rather than acquired.
Working capital: Screener working-capital days were 84, 60, 68, 70 and 81 for FY2022–FY2026. CRISIL puts gross current assets at about 194 days and inventory at about 141 days at 31 March 2026, on its own methodology.
Net worth: CRISIL's figure of INR 201 crore at 31 March 2026 matches Screener. Book value per share is INR 257.
Cash flow
Notes. Screener reports its own "free cash flow" series (15, 42, -5, -39, -20). It differs from the analyst computation above because Screener uses a different capex definition. Both series show the same direction. Dividends declared are derived from DPS multiplied by 7,818,288 shares. Cash dividends paid fall in the following fiscal year. No buyback has been authorized in the period.
Commentary on trends, inflections and drivers
Revenue. Top-line growth accelerated in FY2026 (+24%) after two flat-to-modest years. The drivers were a 36% rise in Coffee revenue and a 20% rise in Logistics. Coffee revenue in a merchant model follows the price of the commodity as much as volume. International coffee prices were exceptionally high through 2024–2025. Part of the growth is therefore probably price pass-through rather than real volume expansion. Management has not disclosed a volume and price split.
Profitability. The decline in profitability is the central problem. Operating margin fell from about 7% in FY2022–FY2023 to 3.3% in FY2024, recovered to 5.7% in FY2025, and slipped back to 4.4% in FY2026, despite record revenue. Net profit in FY2026 (INR 13.16 crore) was lower than in FY2025 (INR 14.53 crore) on 24% more revenue. CRISIL notes that operating profitability stayed in a 3–8% band over the five fiscals to 2026. Its downgrade trigger is EBITDA margin staying below 3.5%, which FY2026 cleared by less than one percentage point. Other income is volatile and material: INR 21 crore in FY2023, and INR 6.5 crore in Q2 FY2026 alone. It has repeatedly decided whether a quarter shows a profit or a loss.
Balance sheet and cash. In FY2025 the business turned from cash-generative to cash-absorbing. Operating cash flow was minus INR 35 crore in FY2025 and minus INR 22 crore in FY2026, as coffee inventory and receivables grew. Borrowings tripled from INR 23 crore to INR 79 crore over two years and interest cost rose from about INR 4 crore to INR 7 crore. Leverage is still conservative in absolute terms (debt to equity of 0.39x) and CRISIL considers liquidity adequate. Average fund-based limit utilisation was about 63%, and cash-credit utilisation only about 20%, over the 12 months to August 2026. The enlargement of rated bank lines from INR 126.5 crore to INR 153.5 crore in September 2026 suggests management expects inventory financing to grow further.
Returns. Excluding the FY2023 other-income spike, ROE has stayed between 6% and 8%. That is well below India's cost of equity (usually taken as about 12–14%). This explains why the stock trades below book value.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Incorporated | Ownership | Activity | Segment mapping | Source |
|---|---|---|---|---|---|
Aspinwall and Company Limited (parent) | 1920 | Listed | Logistics, Coffee, Plantation, Natural Fibre, leasing | All | Filings |
Malabar Coast Marine Services Pvt Ltd | 1990 | 100% | Logistics and marine-related services | Logistics | CRISIL |
Aspinwall Geotech Ltd | 1994 | 100% | Coir geotextiles for environmental engineering and soil conservation | Others (natural fibre) | CRISIL |
SFS Pharma Logistics Pvt Ltd | 2011 | 100% | Specialised pharma and clinical-trial shipment logistics (offices in Mumbai and Hyderabad) | Logistics | CRISIL; MagicPort |
Aspinwall Healthcare Pvt Ltd | 2020 | 100% | Manufacturing and trading of medical and healthcare products | Others | CRISIL |
Segment revenue (INR Cr)
| Segment revenue (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Coffee (INR Cr) | 101.0 | 109.0 | 120.0 | 131.0 | 178.0 |
Logistics (INR Cr) | 130.0 | 151.0 | 127.0 | 133.0 | 160.0 |
Plantation (INR Cr) | 15.4 | 26.2 | 36.2 | 56.0 | 63.3 |
Others incl. Natural Fibre (INR Cr) | 13.4 | 8.2 | 11.5 | 15.8 | 15.4 |
Total segment revenue (INR Cr) | 259.8 | 294.4 | 294.7 | 335.8 | 416.7 |
Revenue by Segment
| Segment result (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Coffee (INR Cr) | 14.6 | 19.2 | 5.9 | 15.7 | 12.7 |
Logistics (INR Cr) | 12.7 | 14.5 | 13.0 | 10.4 | 12.4 |
Plantation (INR Cr) | 4.0 | 0.5 | 4.1 | 5.0 | 4.4 |
Others incl. Natural Fibre (INR Cr) | -3.1 | -1.5 | 0.3 | 0.4 | -0.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment margin (%)
| Segment margin (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Coffee margin (%) | 14.5 | 17.6 | 4.9 | 12.0 | 7.1 |
Logistics margin (%) | 9.8 | 9.6 | 10.2 | 7.8 | 7.8 |
Plantation margin (%) | 26.1 | 1.9 | 11.2 | 8.8 | 7.0 |
Others margin (%) | -22.8 | -18.5 | 2.8 | 2.8 | -1.9 |
Segment YoY revenue growth (%)
| Segment YoY revenue growth (%) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Coffee growth (%) | 7.9 | 10.1 | 9.2 | 35.9 |
Logistics growth (%) | 16.2 | -15.9 | 4.7 | 20.3 |
Plantation growth (%) | 70.1 | 38.2 | 54.7 | 13.0 |
Others growth (%) | -38.8 | 40.2 | 37.4 | -2.5 |
Contribution to total revenue (%)
| Contribution to total revenue (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Coffee share (%) | 38.9 | 37.0 | 40.7 | 39.0 |
Logistics share (%) | 50.0 | 51.3 | 43.1 | 39.6 |
Plantation share (%) | 5.9 | 8.9 | 12.3 | 16.7 |
Others share (%) | 5.2 | 2.8 | 3.9 | 4.7 |
Segment assets (INR Cr)
| Segment assets (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Coffee assets (INR Cr) | 88.1 | 68.6 | 86.6 | 133.0 | 165.0 |
Logistics assets (INR Cr) | 61.8 | 60.8 | 70.7 | 83.5 | 78.5 |
Plantation assets (INR Cr) | 22.7 | 25.0 | 23.6 | 28.8 | 26.8 |
Others assets (INR Cr) | 23.9 | 23.2 | 25.7 | 27.8 | 30.9 |
Unallocated assets (INR Cr) | 43.2 | 67.8 | 44.0 | 38.6 | 32.0 |
Segment capex (INR Cr)
| Segment capex (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Coffee capex (INR Cr) | 0.34 | 0.15 | 3.41 | 0.49 | 1.54 |
Logistics capex (INR Cr) | 1.41 | 0.88 | 5.36 | 1.24 | 3.18 |
Plantation capex (INR Cr) | 1.32 | 1.99 | 1.75 | 1.53 | 1.05 |
Others capex (INR Cr) | 2.24 | 1.59 | 0.43 | 2.87 | 1.87 |
Unallocated capex (INR Cr) | 0.59 | 0.08 | 1.89 | 1.34 | 1.34 |
Income statement (INR Cr)
| Income statement (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 260 | 295 | 296 | 335.96 | 417.15 |
Total operating expenses (INR Cr) | 241 | 273 | 286 | 317 | 399 |
EBITDA excl. other income (INR Cr) | 19 | 21 | 10 | 19 | 18 |
Other income (INR Cr) | 7 | 21 | 9 | 6 | 10 |
Depreciation (INR Cr) | 4 | 5 | 5 | 5 | 6 |
EBIT incl. other income (INR Cr) | 22 | 38 | 14 | 20.2 | 22.0 |
Finance cost (INR Cr) | 3 | 2 | 4 | 4.07 | 6.84 |
Profit before tax (INR Cr) | 19 | 36 | 10 | 16.1 | 15.2 |
Effective tax rate (%) | 18 | 20 | -12 | 10 | 13 |
Net profit (INR Cr) | 15 | 29 | 11 | 14.53 | 13.16 |
EPS basic and diluted (INR) | 19.53 | 36.52 | 13.66 | 18.58 | 16.83 |
Dividend per share (INR) | 6.0 | 6.0 | 6.0 | 6.5 | 6.5 |
Margins and growth (%)
| Margins and growth (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | 2.8 | 13.5 | 0.3 | 13.6 | 24.2 |
EBITDA (operating) margin (%) | 7.3 | 7.1 | 3.3 | 5.7 | 4.4 |
EBIT margin incl. other income (%) | 8.5 | 12.9 | 4.7 | 6.0 | 5.3 |
Pre-tax margin (%) | 7.3 | 12.2 | 3.4 | 4.8 | 3.6 |
Net margin (%) | 5.8 | 9.8 | 3.7 | 4.3 | 3.2 |
Income Statement and Per-Share Data
| Quarterly metric (INR Cr) | Q1FY2025 | Q2FY2025 | Q3FY2025 | Q4FY2025 | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 |
|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 82.98 | 74.00 | 89.77 | 89.21 | 90.00 | 83.19 | 113.66 | 130.30 | 113.18 |
EBITDA excl. other income (INR Cr) | 4.26 | 4.67 | 6.22 | 3.72 | -1.78 | 0.09 | 10.17 | 9.13 | 1.09 |
Other income (INR Cr) | 2.18 | 1.20 | 1.45 | 1.50 | 1.09 | 6.50 | 0.33 | 2.16 | 1.61 |
Finance cost (INR Cr) | 0.63 | 0.77 | 0.76 | 1.91 | 1.96 | 1.94 | 1.83 | 1.11 | 1.74 |
Profit before tax (INR Cr) | 4.58 | 3.83 | 5.64 | 2.05 | -3.97 | 3.27 | 7.19 | 8.71 | -0.54 |
Net profit (INR Cr) | 3.67 | 3.78 | 4.82 | 2.26 | -3.27 | 2.80 | 7.62 | 6.01 | -0.70 |
EPS (INR) | 4.69 | 4.83 | 6.17 | 2.89 | -4.18 | 3.58 | 9.75 | 7.69 | -0.90 |
Balance Sheet
| Balance sheet (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Equity share capital (INR Cr) | 8 | 8 | 8 | 8 | 8 |
Reserves (INR Cr) | 146 | 169 | 175 | 185 | 193 |
Total equity / net worth (INR Cr) | 154 | 177 | 183 | 193 | 201 |
Total borrowings (INR Cr) | 24 | 17 | 23 | 69 | 79 |
Other liabilities (INR Cr) | 62 | 52 | 44 | 50 | 53 |
Total assets (INR Cr) | 240 | 246 | 251 | 312 | 333 |
Net fixed assets (INR Cr) | 82 | 81 | 87 | 84 | 89 |
Capital work in progress (INR Cr) | 1 | 1 | 1 | 3 | 2 |
Investments (INR Cr) | 2 | 2 | 1 | 1 | 1 |
Other assets incl. inventory, receivables, cash (INR Cr) | 155 | 161 | 162 | 224 | 241 |
Cash flow (INR Cr)
| Cash flow (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operations (INR Cr) | 16 | 35 | 4 | -35 | -22 |
Cash from investing (INR Cr) | 3 | 9 | -7 | -23 | 20 |
Cash from financing (INR Cr) | -17 | -13 | -1 | 37 | -3 |
Net cash flow (INR Cr) | 2 | 31 | -4 | -21 | -5 |
Capex, sum of segment capex (INR Cr) | 5.9 | 4.7 | 12.8 | 7.5 | 9.0 |
Free cash flow, CFO minus capex (INR Cr) | 10.1 | 30.3 | -8.8 | -42.5 | -31.0 |
Dividend declared for the year, DPS x shares (INR Cr) | 4.7 | 4.7 | 4.7 | 5.1 | 5.1 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity, analyst-computed (%) | 10.1 | 17.5 | 6.1 | 7.7 | 6.7 |
ROA on average assets, analyst-computed (%) | 6.3 | 11.9 | 4.4 | 5.2 | 4.1 |
ROCE, Screener (%) | 10 | 12 | 7 | 9 | 6 |
ROIC, 25% normalized tax, analyst-computed (%) | 9.3 | 15.3 | 5.3 | 6.5 | 6.1 |
Debt to equity (x) | 0.16 | 0.10 | 0.13 | 0.36 | 0.39 |
Gross debt to EBITDA (x) | 1.3 | 0.8 | 2.3 | 3.6 | 4.4 |
Interest coverage, EBIT to finance cost, analyst-computed (x) | 7.3 | 19.0 | 3.5 | 5.0 | 3.2 |
Asset turnover, revenue to average assets (x) | 1.10 | 1.21 | 1.19 | 1.19 | 1.29 |
Debtor days | 39 | 29 | 32 | 37 | 44 |
Inventory days | 393 | 280 | 206 | 307 | 272 |
Payable days | 68 | 49 | 28 | 33 | 30 |
Cash conversion cycle (days) | 364 | 260 | 210 | 312 | 287 |
Dividend payout (%) | 31 | 16 | 44 | 35 | 39 |
Geographic revenue (INR Cr)
| Geographic revenue (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
India (INR Cr) | 170.0 | 201.0 | 193.0 | 225.0 | 280.0 |
Europe (INR Cr) | 72.2 | 84.5 | 92.1 | 98.8 | 119.0 |
Americas incl. Canada and South America (INR Cr) | 10.8 | 3.5 | 5.2 | 6.6 | 10.8 |
Rest of world (INR Cr) | 7.0 | 5.1 | 5.2 | 5.3 | 8.2 |
Geographic growth YoY (%)
| Geographic growth YoY (%) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
India growth (%) | 18.2 | -4.0 | 16.6 | 24.4 |
Europe growth (%) | 17.0 | 9.0 | 7.3 | 20.4 |
Americas growth (%) | -67.6 | 48.6 | 26.9 | 63.6 |
Rest of world growth (%) | -27.1 | 2.0 | 1.9 | 54.7 |
Geographic share of revenue (%)
| Geographic share of revenue (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
India share (%) | 65.4 | 68.3 | 65.5 | 67.0 | 67.0 |
Europe share (%) | 27.8 | 28.7 | 31.3 | 29.4 | 28.5 |
Americas share (%) | 4.2 | 1.2 | 1.8 | 2.0 | 2.6 |
Rest of world share (%) | 2.7 | 1.7 | 1.8 | 1.6 | 2.0 |
Capital Markets
| Measure | Value | Source |
|---|---|---|
Price (19-Oct-2026) | INR 236 | Screener |
Price (8-Oct-2026) | INR 245.89; year to date minus 5.82% | Zonebourse |
1-year return | About minus 8% | Screener |
3-year CAGR | About minus 1% | Screener |
5-year CAGR | About 6% | Screener |
52-week high / low | INR 300 / INR 200 | Screener |
All-time high | INR 579.50 (27-Dec-2017) | TradingView |
All-time low | INR 71.40 (23-Mar-2020) | TradingView |
Valuation Multiples
| Multiple | Aspinwall | Basis |
|---|---|---|
P/E, TTM (x) | 11.7 | TTM consolidated PAT of INR 15.73 crore (Q2 FY2026 to Q1 FY2027). Screener displays 15.5x, apparently on a different earnings basis |
P/E, FY2026 (x) | 14.0 | FY2026 EPS of INR 16.83 |
P/B (x) | 0.92 | Book value of INR 257 per share |
EV/EBITDA, TTM (x) | About 12.3 | EV of about INR 252 crore (market cap 184 + debt 79 − cash of about 11); TTM EBITDA INR 20.5 crore |
EV/Sales, TTM (x) | About 0.57 | TTM revenue of INR 440 crore |
Dividend yield (%) | 2.75 | INR 6.50 / INR 236 |
Dividend metric
| Dividend metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 6.0 | 6.0 | 6.0 | 6.5 | 6.5 |
Dividend payout ratio (%) | 31 | 16 | 44 | 35 | 39 |
Total dividend declared (INR Cr) | 4.7 | 4.7 | 4.7 | 5.1 | 5.1 |
Analyst Conclusions
Guidance and consensus
Management guidance: none issued. The Directors' Report gives qualitative optimism only for SFS Pharma Logistics.
Consensus: no sell-side coverage. Simply Wall St reports zero analysts and insufficient data for price targets.
CRISIL's forward view: net cash accrual of INR 9–11 crore a year, no significant debt-funded capex, and a stable outlook.
Bull case
-
Coffee spread normalization. Coffee earned 12–18% segment margins in FY2022, FY2023 and FY2025. If FY2026 revenue (INR 178 crore) is held at a 12% margin, segment profit would be about INR 21 crore, against INR 12.7 crore reported. That would add roughly INR 6 crore to after-tax profit, a significant amount relative to a market cap of INR 184 crore.
-
Asset backing. The stock trades at 0.92x book (INR 201 crore of equity) and about 0.57x TTM sales, with a 2.75% dividend yield. There is no term debt. Downside appears well cushioned.
-
Growth plus diversification. The second half of FY2026 showed what the business can earn. Q3 and Q4 together produced INR 13.6 crore of PAT on INR 244 crore of revenue. Revenue grew 24% in FY2026 and 26% in Q1 FY2027.
Bear case
-
Value trap economics. ROE has stayed between 6% and 8% for three years. Each additional rupee of coffee revenue requires a large inventory investment. Operating cash flow was negative in both FY2025 and FY2026 despite record revenue.
-
Margin fragility. FY2026 EBITDA margin of 4.4% and Q1 FY2027 of 0.96% sit close to CRISIL's 3.5% downgrade trigger. Commodity and currency exposure is unhedged.
-
Structural headwinds and governance stasis. The Others segment is pressured by the US tariff and weak mattress demand. There is no investor communication, no institutional ownership and a shrinking retail base. These factors remove the usual catalysts for re-rating.
Catalysts and monitorables (next 12 months)
| Expected timing | Catalyst / monitorable | What to watch |
|---|---|---|
| Early November 2026 | Q2 FY2027 results (trading window closed 1-Oct-2026) | Coffee margin; other-income dependence; borrowings |
| February 2027 | Q3 FY2027 results | Seasonal peak; whether OPM exceeds 8% |
| May 2027 | FY2027 audited results and dividend | Full-year OCF sign; DPS maintained at INR 6.50 or more |
| Ongoing | ICE arabica and robusta prices; Indian rubber prices | Spread and segment margin direction |
| Ongoing | US–India tariff developments | Natural-fibre export pricing |
| Ongoing | CRISIL surveillance | Rating action if margin stays below 3.5% |
| Ongoing | Leasing income from Aspinwall House; SFS Pharma growth | Contribution to Others and Logistics |
Analyst verdict
Aspinwall and Company is a durable but under-earning business. It survived 159 years, a change of ownership in the 1970s and a COVID-era share price collapse to INR 71. It enters FY2027 with record revenue (INR 417 crore), an unbroken dividend record, nil term debt and an investment-grade domestic rating (CRISIL BBB/Stable). Those facts set a firm floor. At 0.92x book, roughly 12x trailing earnings and a 2.75% yield, the market is not paying for any growth.
That floor comes with a low ceiling, however. The FY2026 numbers show the core tension clearly. Revenue rose 24%, while net profit fell 9%, operating cash flow was minus INR 22 crore, borrowings reached INR 79 crore and interest coverage slid to about 3x. The coffee franchise, now the largest segment, converts commodity inflation into revenue but not into proportionate profit. It also absorbs balance-sheet capacity. Logistics is a steady INR 10–14 crore earner but is not growing its margin. Plantation has re-rated with rubber prices and is now plateauing. Natural fibre is a drag. With ROE of 6–8% and no hedging policy, the business destroys value relative to its cost of equity in an average year.
Change would require one of three things. The first is a sustained recovery in coffee spreads toward historical 12%-plus margins. The second is management choosing to release working capital and return cash, or to monetise assets such as the Aspinwall House leasing. The third is a step-up in disclosure that brings in institutional interest. None of these is signalled in current filings. The 64.46% promoter holding has been unchanged for at least a decade and the board composition is stable, so strategic inflection is likely to come slowly, if at all.
Verdict: a low-risk, low-return, asset-backed micro-cap. It suits patient, income-oriented holders who can tolerate illiquidity. It is unlikely to re-rate without margin and cash-flow evidence. The two items most likely to move the stock in the next twelve months are coffee segment margin and the sign of operating cash flow.
Source register (principal documents)
| # | Source | Type | Date accessed / dated |
|---|---|---|---|
| 1 | NSE board outcome: FY2024 audited results and dividend | Primary filing | 29-May-2024 |
| 2 | NSE board outcome: Q2 FY2026 results | Primary filing | 3-Nov-2025 |
| 3 | NSE board outcome: Q3 FY2026 results | Primary filing | 6-Feb-2026 |
| 4 | NSE board outcome: Q1 FY2027 results | Primary filing | 5-Aug-2026 |
| 5 | NSE intimation: director re-appointments | Primary filing | 1-Aug-2023 |
| 6 | Annual Report FY2025-26, Directors' Report (via IIFL/Goodreturns reproduction) | Primary (reproduced) | Filed 30-Jun-2026 |
| 7 | CRISIL Ratings rationale | Rating agency | 28-Sep-2026 |
| 8 | CRISIL credit bulletin | Rating agency | 8-Oct-2026 |
| 9 | Screener.in consolidated financials, shareholding and announcements | Aggregator (filing-derived) | 19/20-Oct-2026 |
| 10 | Zonebourse/MarketScreener segment and geography data | Aggregator (S&P/FactSet-derived) | 8-Oct-2026 |
| 11 | ScanX: FY2026 results, AGM, non-encumbrance | News (filing summaries) | May–Jul 2026 |
| 12 | Business Standard / Capital Market: Q1 FY2027 results | News | 6-Aug-2026 |
| 13 | Simply Wall St, Morningstar, TipRanks, TradingView, StockAnalysis | Aggregators | 2025–2026 |
| 14 | CCL Products, Harrisons Malayalam, Tiger Logistics, Patel Integrated FY2026 results coverage | Peer data (news) | May–Aug 2026 |
| 15 | ICCI Cochin, IIFL, PL India, Pocketful company histories | Historical background | Various |
| 16 | The News Minute, The Art Newspaper, Onmanorama, News Arena India (Aspinwall House / Biennale) | Media | 2022–2026 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / key dates | Background | Age | Compensation | Source |
|---|---|---|---|---|---|---|
Rama Varma (DIN 00031890) | Managing Director (Executive; promoter group) | Whole-Time Director from 1-Aug-2005; MD from 1-Apr-2007; re-appointed for 3 years from 1-Aug-2026 (special resolution passed with 99.9996% of votes cast) | B.Sc.; Director of Varma Exports Ltd; former Independent Director of Nirlon Ltd (2006–2019) | — | — | ScanX; Simply Wall St; MarketScreener |
Thalasseril Raghavankutty (T. R.) Radhakrishnan | Executive Director and Chief Financial Officer | Remuneration approved at 106th AGM (23-Jul-2026) | Long-serving finance head (details not disclosed) | — | — | ScanX |
Mahadev Lakshminarayanan | Chairman and Independent Director | Independent Director from about 2017; Chairman from 2023 (Simply Wall St shows about 7 years on the board) | — | — | About INR 1.66 million (aggregator figure, year unspecified) | Blinkx; Simply Wall St |
Chemprol Raja Raja Varma (C. R. R. Varma) (DIN 00031924) | Non-Executive Director (promoter) | Over four decades with the company as MD and then Non-Executive Director; re-appointed in 2023; director in three subsidiaries | Promoter family | — | — | NSE intimation 1-Aug-2023 |
Avittam Thirunal Adithya Varma | Non-Executive Director (promoter) | Appointed 17-Aug-2017 | Commerce graduate | Born 15-Apr-1971 (55) | — | Blinkx; MarketScreener |
Company Secretary | Company Secretary and Compliance Officer | — | — | — | — | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1-Aug-2023 | Rama Varma re-appointed MD; C. R. R. Varma re-appointed Non-Executive Director | Routine renewal (NSE intimation) |
27-May-2026 | Board recommends re-appointment of Rama Varma as MD for 3 years from 1-Aug-2026 | FY2026 board meeting (ScanX) |
23-Jul-2026 | AGM approves the MD re-appointment and the ED & CFO remuneration | All six resolutions passed (ScanX) |
Shareholding Trend
| Shareholder category (% of equity) | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Promoters (%) | 64.46 | 64.46 | 64.46 | 64.46 | 64.46 | 64.46 | 64.46 | 64.46 |
FIIs (%) | 0.00 | 0.05 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public incl. DIIs (%) | 35.54 | 35.49 | 35.53 | 35.54 | 35.54 | 35.54 | 35.54 | 35.54 |
Number of shareholders | 5,011 | 4,823 | 4,742 | 4,691 | 4,611 | 4,676 | 4,526 | 4,405 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning versus Aspinwall | Source / note |
|---|---|---|---|---|
Coffee | CCL Products (India) Ltd | Listed; instant coffee and green coffee | Far larger (FY2026 revenue INR 4,457 crore); value-added instant coffee rather than specialty green export | CCL FY2026 results |
Coffee | Tata Consumer Products (plantation coffee, after the merger of Tata Coffee) | Listed conglomerate | Integrated grower, processor and brand owner; much larger scale | General industry knowledge |
Coffee | ofi (Olam Food Ingredients) India | Global merchant | Global origination and financing advantages | General industry knowledge |
Coffee | Neumann Kaffee Gruppe / Ned Commodities, Sucafina, Volcafe (ED&F Man) | Global green-coffee merchants with India sourcing | Buy competitively at origin; strong hedging ability that Aspinwall lacks | General industry knowledge |
Coffee | Allanasons and other Indian coffee exporters | Private exporters | Similar exporter model | General industry knowledge |
Logistics | Tiger Logistics (India) Ltd | Listed freight forwarder | Larger (FY2026 revenue INR 572.82 crore); pure-play forwarding | Tiger Logistics FY2026 results |
Logistics | Patel Integrated Logistics Ltd | Listed multimodal and air cargo | Comparable scale (FY2026 total income INR 357.25 crore) | Patel FY2026 results |
Logistics | Allcargo / ECU Worldwide, Transworld, JM Baxi | National and global logistics and ship agency | Much larger networks | General industry knowledge |
Logistics | Local CHAs and ship agents at Kochi, Mangaluru and Chennai | Fragmented private players | Aspinwall competes on legacy relationships | CRISIL (long track record) |
Plantation (rubber) | Harrisons Malayalam Ltd | Listed tea and rubber planter (Kerala) | Larger and diversified planter (FY2026 revenue INR 539.08 crore) | Harrisons FY2026 results |
Plantation (rubber) | Malayalam Plantations, AVT, Rubber Board-linked estates, smallholders | Planters | Most Indian rubber comes from smallholders, so the market is a price-taker market | General industry knowledge |
Natural fibre | Kerala and Tamil Nadu coir exporters; Sheela Foam (Kurlon) in coir mattresses | Private and listed | Aspinwall is a small niche participant | General industry knowledge |
Peer Comparison FY2026
| Metric (FY2026) | Aspinwall | CCL Products | Harrisons Malayalam | Tiger Logistics |
|---|---|---|---|---|
Revenue from operations (INR Cr) | 417.15 | 4,457.37 | 539.08 | 572.82 |
Revenue growth YoY (%) | 24.2 | 43.5 | 4.9 | 6.8 |
EBITDA / operating profit (INR Cr) | 18 | 741.37 | 48.73 | — |
EBITDA margin (%) | 4.4 | 16.6 | 9.0 | — |
Net profit (INR Cr) | 13.16 | 388.11 | 29.15 | 21.52 |
Net margin (%) | 3.2 | 8.7 | 5.4 | 3.8 |
Recent Developments
There were no layoffs, litigation, regulatory actions, restructurings or guidance revisions in the period, according to the filings reviewed.



